These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32738178)

  • 41. Distinct subcellular trafficking resulting from monomeric vs multimeric targeting to endothelial ICAM-1: implications for drug delivery.
    Ghaffarian R; Muro S
    Mol Pharm; 2014 Dec; 11(12):4350-62. PubMed ID: 25301142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular endothelial platelet endothelial cell adhesion molecule 1 (PECAM-1) regulates advanced metastatic progression.
    DeLisser H; Liu Y; Desprez PY; Thor A; Briasouli P; Handumrongkul C; Wilfong J; Yount G; Nosrati M; Fong S; Shtivelman E; Fehrenbach M; Cao G; Moore DH; Nayak S; Liggitt D; Kashani-Sabet M; Debs R
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18616-21. PubMed ID: 20926749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigration.
    Christofidou-Solomidou M; Kennel S; Scherpereel A; Wiewrodt R; Solomides CC; Pietra GG; Murciano JC; Shah SA; Ischiropoulos H; Albelda SM; Muzykantov VR
    Am J Pathol; 2002 Mar; 160(3):1155-69. PubMed ID: 11891211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.
    Hood ED; Greineder CF; Dodia C; Han J; Mesaros C; Shuvaev VV; Blair IA; Fisher AB; Muzykantov VR
    J Control Release; 2012 Oct; 163(2):161-9. PubMed ID: 22974832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brain.
    Marcos-Contreras OA; Brenner JS; Kiseleva RY; Zuluaga-Ramirez V; Greineder CF; Villa CH; Hood ED; Myerson JW; Muro S; Persidsky Y; Muzykantov VR
    J Control Release; 2019 May; 301():54-61. PubMed ID: 30871995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endothelial cell expression of adhesion molecules is induced by fetal plasma from pregnancies with umbilical placental vascular disease.
    Wang X; Athayde N; Trudinger B
    BJOG; 2002 Jul; 109(7):770-7. PubMed ID: 12135213
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Significance of platelet endothelial cell adhesion molecule-1 (PECAM-1) and intercellular adhesion molecule-1 (ICAM-1) expressions in preeclamptic placentae.
    Goksu Erol AY; Nazli M; Elis Yildiz S
    Endocrine; 2012 Aug; 42(1):125-31. PubMed ID: 22396143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biocompatible coupling of therapeutic fusion proteins to human erythrocytes.
    Villa CH; Pan DC; Johnston IH; Greineder CF; Walsh LR; Hood ED; Cines DB; Poncz M; Siegel DL; Muzykantov VR
    Blood Adv; 2018 Feb; 2(3):165-176. PubMed ID: 29365311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The effect of 7-ketocholesterol on surface ICAM-1 and PECAM-1 expression in human aortic endothelial cells].
    Dorantowicz R; Łuczak E; Broncel M
    Pol Merkur Lekarski; 2014 Apr; 36(214):233-9. PubMed ID: 24868894
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1.
    Garnacho C; Shuvaev V; Thomas A; McKenna L; Sun J; Koval M; Albelda S; Muzykantov V; Muro S
    Blood; 2008 Mar; 111(6):3024-33. PubMed ID: 18182571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm.
    Howard M; Zern BJ; Anselmo AC; Shuvaev VV; Mitragotri S; Muzykantov V
    ACS Nano; 2014 May; 8(5):4100-32. PubMed ID: 24787360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cross-linking of brain endothelial intercellular adhesion molecule (ICAM)-1 induces association of ICAM-1 with detergent-insoluble cytoskeletal fraction.
    Amos C; Romero IA; Schültze C; Rousell J; Pearson JD; Greenwood J; Adamson P
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):810-6. PubMed ID: 11348879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cloning and characterization of a single-chain fragment of monoclonal antibody to ACE suitable for lung endothelial targeting.
    Balyasnikova IV; Berestetskaya JV; Visintine DJ; Nesterovitch AB; Adamian L; Danilov SM
    Microvasc Res; 2010 Dec; 80(3):355-64. PubMed ID: 20888351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of adhesion molecule expression by human brain microvessel endothelium on cancer cell adhesion.
    Brayton J; Qing Z; Hart MN; VanGilder JC; Fabry Z
    J Neuroimmunol; 1998 Aug; 89(1-2):104-12. PubMed ID: 9726832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion.
    Sun Z; Wang X; Lasson A; Böjesson A; Annborn M; Andersson R
    Scand J Gastroenterol; 2001 Jan; 36(1):55-65. PubMed ID: 11218240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ICAM-3 regulates lymphocyte morphology and integrin-mediated T cell interaction with endothelial cell and extracellular matrix ligands.
    Campanero MR; Sánchez-Mateos P; del Pozo MA; Sánchez-Madrid F
    J Cell Biol; 1994 Nov; 127(3):867-78. PubMed ID: 7525599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet endothelial cell adhesion molecule-1, a putative receptor for the adhesion of Streptococcus pneumoniae to the vascular endothelium of the blood-brain barrier.
    Iovino F; Molema G; Bijlsma JJ
    Infect Immun; 2014 Sep; 82(9):3555-66. PubMed ID: 24914219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse.
    Nakashima Y; Raines EW; Plump AS; Breslow JL; Ross R
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):842-51. PubMed ID: 9598845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface.
    Murciano JC; Muro S; Koniaris L; Christofidou-Solomidou M; Harshaw DW; Albelda SM; Granger DN; Cines DB; Muzykantov VR
    Blood; 2003 May; 101(10):3977-84. PubMed ID: 12531816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nanocell targeting using engineered bispecific antibodies.
    Taylor K; Howard CB; Jones ML; Sedliarou I; MacDiarmid J; Brahmbhatt H; Munro TP; Mahler SM
    MAbs; 2015; 7(1):53-65. PubMed ID: 25523746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.